| Stage | EOG | % of rev | DVN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.6B | 100.00% | $7.4B | 100.00% | EOG ×1.15 |
| Gross profit | $7.4B | 86.65% | $4.2B | 55.95% | EOG +30.7pp |
| Operating income | $3.5B | 41.21% | $2.3B | 31.31% | EOG +9.9pp |
| Pre-tax income | $3.5B | 40.87% | $2.4B | 32.14% | EOG +8.7pp |
| Net income | $2.7B | 31.81% | $1.9B | 25.77% | EOG +6.0pp |
| Stage | EOG | DVN | Gap · A − B |
|---|---|---|---|
| Revenue | $8.6B100.00% | $7.4B100.00% | EOG ×1.15 |
| Gross profit | 86.65%$7.4B | 55.95%$4.2B | EOG +30.7pp |
| Operating income | 41.21%$3.5B | 31.31%$2.3B | EOG +9.9pp |
| Pre-tax income | 40.87%$3.5B | 32.14%$2.4B | EOG +8.7pp |
| Net income |
| 31.81%$2.7B |
| 25.77%$1.9B |
| EOG +6.0pp |
No disclosed counterparties: DVN.
None